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Infection with Mycobacterium tuberculosis (TB) induces pulmonary immunopathology mediated by classical Th1 type of acquired
immunity with hepatic involvement in up to 80% of disseminated cases. Since PPAR agonists cause immune responses character-
ized by a decrease in the secretion of Th1 cytokines, we investigated the impact of activating these receptors on hepatic pathology
associated with a well-characterized model of Th1-type pulmonary response. Male Fischer 344 rats were either maintained on a
drug-free diet (groups I and II), or a diet containing diethylhexylphthalate (DEHP), a compound transformed in vivo to metabo-
lites known to activate PPARs, for 21 days (groups III and IV). Subsequently, animals were primed with Mycobacterium bovis
puriﬁed protein derivative (PPD) in a Complete Freund’s Adjuvant. Fifteen days later, animals in groups II and IV were challenged
with Sepharose 4B beads covalently coupled with PPD, while animals in groups I and III received blank Sepharose beads. Animals
with Th1 response (group II) showed a marked structural disruption in the hepatic lobule. Remarkably, these alterations were
conspicuously absent in animals which received DEHP (group IV), despite noticeable accumulation of T cells in the periportal tri-
ads. Immunostaining and confocal microscopy revealed hepatic accumulation of IFNγ+ Th1 and IL-4+ Th2 cells in animals from
groups II and IV, respectively. Our data suggest a PPARα-mediated suppression of the development of a Th1 immune response
in the liver, resulting in hepatoprotective eﬀect. However, potentially negative consequences of PPAR activation, such as decreased
ability of the immune system to ﬁght infection and interference with the eﬃcacy of vaccines designed to evoke Th1 immune re-
sponses, remain to be investigated.
Copyright © 2007 Mostafa Z. Badr et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Although primary hepatic TB is an uncommon disease,
pulmonary TB with hepatic involvement represents up to
80% of disseminated cases of this disease [1]. Reasons for
the involvement of the liver in this disease are unclear.
However, since pulmonary TB is known to evoke classi-
cal Th1-type of acquired immunity [2], it is conceivable
that an overwhelming Th1-type immune reactions in the
lungs may result in a systemic immune response which
causes collateral damage to other organs, including the liver
[3, 4].
PPARs are members of the steroid receptor superfamily
[5].ActivationofthePPARαreceptorsubtypeinducesthese-
cretion of the prototypic Th2 cytokine IL-4, while decreasing
that of the prototypic Th1 cytokine, IFNγ, in both murine
andhumanTcells[6].Furthermore,inprimaryhumanhep-
atocytes and hepatoma cells, PPAR activators suppress IL-1-
inducedC-reactiveproteinaswellasIL-6inducedﬁbrinogen
expression, the major acute-phase response proteins in hu-
mans [7].
This study was therefore undertaken to (1) analyze
whether experimentally-induced Th1-type immune re-
sponse in the lungs, initiated by Mycobacterium bovis,m a y2 PPAR Research
lead to immunopathological abnormalities in the liver, and
(2) investigate the inﬂuence of activating PPAR receptors,
whichareabundantintheliver[8],onsuchhepaticresponse.
We elected to use diethylhexylphthalate, one of the most
abundant environmental pollutants which is transformed in
the body to metabolites known to activate PPARs [8–15].
2. MATERIALS AND METHODS
2.1. Animals
Male Fischer 344 rats (250–300gm body weight) were ob-
tainedfromTaconic,HudsonNY.Uponarrival,animalswere
acclimatized for a week prior to experiment in an AAALC-
accredited facility at the University of Missouri-Kansas City,
on a daily cycle of alternating 12-hour periods of light and
dark. All procedures were performed in compliance with rel-
evant regulations.
2.2. InductionofTh1response
Rats were randomly divided into 4 groups: groups I and II
received a drug-free diet, while groups III and IV received
a diet containing 12.000ppm diethylhexylphthalate (DEHP)
(Sigma Aldrich, St Louis, Missouri) for 21 days. Subse-
quently, rats in all groups received intraperitoneally 20μg
of Mycobacterium bovis puriﬁed protein derivative (PPD)
(Mycos Research, Loveland, Colorado) incorporated into
0.25ml of complete Freund’s adjuvant (CFA; Sigma Aldrich,
St Louis, Missouri). Fifteen days later, animals in groups II
and IV were challenged intravenously with approximately
6000 beads of Sepharose 4B covalently coupled with PPD,
in 0.5ml PBS. Animals in groups I and III received the
SepharosebeadswithoutPPD.Allanimalsremainedontheir
respective diets for additional 15 days, after which time they
were sacriﬁced, and livers were removed and kept in neutral-
ized 10% formalin until processing.
2.3. Histopathologicalandimmunohistochemical
studies
Tissue specimens were paraﬃn-embedded, and 4μms e c -
tions were deparaﬃnized and stained with hematoxylin and
eosin. A semiquantitative evaluation of the histological dam-
age to the liver was carried out according to previously pub-
lished methodology [16]. Brieﬂy, two pathologists, who were
unaware of the treatments, objectively evaluated the tissue
for the reported speciﬁc types of injury. A mean score was
assigned to each slide ranging from 10, indicating the pres-
enceofdeﬁnitedamage,to40,indicatingveryseveredamage.
A score of 5 indicated that some areas had speciﬁc damage
whereas other areas were without morphological changes.
Slidesoftissueswithnormalappearancereceiv edascoreof0.
For immunohistochemical studies, slides were quenched
using3%hydrogenperoxideinmethanol.Sectionswerethen
hydrated through gradient alcohols and phosphate-buﬀered
saline. For antigen retrieval, slides were placed in neutral-
ized target retrieval solution (Dako, Carpinteria, Califor-
nia) for 30 minutes in a steamer. Slides were then exposed
for one hour, at room temperature, to primary antibodies:
rabbit anti-CD3 (dilution 1 : 600, Dako), and mouse anti-
CD79 (dilution 1 : 300, Neomarkers, Freemont, California).
Blocking solution was used as a negative control on dupli-
cate slides. Secondary antibody was biotinylated goat anti-
immunoglobulins of mouse, rabbit, guinea pig, and rat pri-
mary antibodies. An avidin-biotin-peroxidase complex (Im-
munodetection System Biogenex, San Ramon, California)
with DAB as a chromogen was used for detecting antibody
binding.
2.4. Th1/Th2hepaticresponses
L i v e rt i s s u es e c t i o n s( 8 μm) were deparaﬃnized and pro-
cessedforantigenretrievalbyboiling in10mMcitratebuﬀer
(pH 6.0) for 20 minutes, cooled for 10 minutes, and then
washed with PBS [16]. Subsequently, slides were conditioned
with SuperBlock blocking buﬀer in PBS (Pierce, Rockford,
Illinois) for 30 minutes at room temperature and were then
incubated for 1 hour with the primary antibody (IL-4 and
IFN-γ, Proscience, Inc., Poway, California) diluted in 10%
SuperBlock blocking buﬀer according to the manufacturer’s
protocol. After incubation, slides were rinsed with PBS and
washed with PBS (3 × 3 minute). The slides were then in-
cubated for 1 hour with the secondary antibody (goat anti-
mouse isotype-speciﬁc antibodies labeled with Alexa Fluor
488, or Alexa Fluor 568; Molecular Probes, Eugene, Ore-
gon) diluted in 150μl of 10% SuperBlock blocking buﬀer.
Slides were washed and mounted with Prolong Antifade Kit
(Molecular Probes, Eugene, Oregon), protected with a cover
slip, and stored in the dark until analysis by confocal mi-
croscopy. Background autoﬂuorescence was controlled by
using tissue sections which were processed as above, except
the incubation with primary antibodies. Fluorescence was
registered as 1.0μm optical sections in parallel in the 488nm
(green), or 568nm (red) channels, using Nikon software EZ-
C1, version 2.20, equipped with Ar/He/Ne lasers [17].
3. RESULTS
3.1. EffectofTh1responseonliverhistopathology
Figure 1 shows representative hematoxylin and eosin-stained
sections of livers from animals maintained on control, as
well as DEHP-containing diets, in the absence of any fur-
ther treatment. While livers of control animals did not show
any morphological abnormality (see Figure 1(a)), dietary
DEHP caused an intense eosinophilic cytoplasmic staining
of hepatocytes, albeit without substantially altering the lobu-
larstructureoftheorgan(seeFigure 1(b)).Inaddition,some
cells demonstrated particularly intense eosinophilia and nu-
clei that were smaller and intensively hyperchromatic, with
possible mitotic ﬁgures (see Figure 1(b)).
Immune response induced by PPD in animals main-
tained on control diet (groups I and II) resulted in the hep-
atic lobule disruption, vascular congestion, mild fatty inﬁl-
tration, and appearance of many pyknotic nuclei (see Fig-
ures 1(c) and 1(e)). The damage was more severe in animals
which received both soluble PPD and PPD-coupled beadsMostafa Z. Badr et al. 3
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Figure 1: Eﬀect of DEHP on Th1-Induced damage of hepatocellular structure. (a) Representative liver sections from rats fed either a drug-free
diet; (b) DEHP-containing diet. (c) Animals on drug-free diet + naked sepharose beads, group I; (d) DEHP diet + naked sepharose beads,
group III; (e) drug-free diet + PPD-coupled sepharose beads, group II; or (f) DEHP diet + PPD-coupled sepharose beads, group IV. Tissues
from 5 animals per group were stained with hematoxylin and eosin following standard techniques. Photos are 100x.
(group II), with more evident parenchymal disruption, a
larger number of pyknotic nuclei, and scattered inﬂamma-
torycellsinﬁltratingtheparenchyma(seeFigure 1(e)).These
alterations were absent in the livers of rats receiving the
DEHP diet (see Figures 1(d) and 1(f)), where the lobular
structure remained normal with modest inﬁltration of in-
ﬂammatory cells in the periportal triads. A semiquantitative
evaluation of the hepatic morphological alterations in all an-
imal groups is summarized in Figure 2.
3.2. HepaticimmuneresponsetoMycobacterium
bovisPPDandshiftingtheTh1/Th2balancein
responsetoDEHP
In livers of rats maintained on control diet, only scattered
T (see Figure 3) and B (not shown) cells were observed fol-
lowing treatment with sepharose beads, in the presence or
absence of Mycobacterium bovis PPD. The presence of T cells
became evident in livers of rats maintained on the DEHP-
containing diet, particularly in the portal triad of animals
t r e a t e dw i t hP P Dc o u p l e db e a d s( s e eFigure 3(d)).
Double staining with antibodies against Th1-type cy-
tokine IFN-γ (labeled with red ﬂuorochrome) and Th2-type
cytokineIL-4(labeledwithgreenﬂuorochrome)hasrevealed
IL-4+/IFN-γ+++ phenotypeofliver-associatedTcellsinPPD-
immunized animals kept on drug-free diet (see Figure 4(a)).
In PPD-immunized animals receiving DEHP-diet, however,
liver associated T cells were stained with bright green color
indicating a full acquisition of IL-4+++/IFN-γ− (Th2) phe-
notype by the cells (see Figure 4(b)).
4. DISCUSSION
In human diseases and animal models, it has been demon-
strated that speciﬁc immune responses mediated by the Th1-
related cytokines are associated with resistance to infection
caused by virsus and intracellular bacteria, while Th2-related
cytokines exert opposing negative immunoregulatory func-
tions [2]. However, since Th1 lymphocytes are major pro-
ducers of IFNγ, a critical cytokine in the orchestration of po-
tent pro-inﬂammatory response, it is conceivable that Th1
immune cells may not only contribute to the elimination
of pathogens, but may also precipitate damage of host cells
[3, 4].
4.1. PPARα,immunedeviation,and
hepatocellularprotection
P P A R sh a v eb e e nd e m o n s t r a t e dt oh a v er e g u l a t o r ye ﬀects on
inﬂammatory and immune responses [5]. Indeed, agonists
of these receptors have been shown to modulate cellular re-
sponses to a variety of inﬂammatory agents [5], as well as to
alter immune cell functions [5, 6]. Activation of PPARα in
cultures of murine or human T cells inhibited IFNγ, while
promoting IL-4 secretion [6]. In mice, either of the PPARα
agonists, gemﬁbrozil or fenoﬁbrate inhibited clinical signs of
Th1-mediated autoimmune encephalomyelitis [6].4 PPAR Research
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Figure 2: Pathological evaluation of liver response to PPD.L i v e r so f
rats fed either a drug-free diet + PPD-coupled sepharose beads,
Control; or DEHP diet + PPD-coupled sepharose beads, DEHP
were evaluated as described under Section 2. Results are means ±
SD from 4-5 rats per group.
In this study, evoking a Th1 response through exposure
to PPD resulted in hepatic lobule disruption (see Figure 1).
However, these morphological alterations were essentially
absent in animals subjected to the same protocol, but receiv-
ing DEHP-containing diet. This hepatoprotective eﬀect oc-
curred concomitantly with a change in Th1/Th2 balance in
liver-associated T lymphocytes. This eﬀect can be character-
ized as a shift from the liver damaging IFNγ-controlled Th-1
response to the liver protective Th2 response associated with
IL-4-positive lymphocytes (see Figure 4).
Simultaneous detection of IL-4 (green) and IFN-γ (red)
by double ﬂuorescence has revealed IL-4+/IFN-γ+++ Tc e l l s
identiﬁed by orange ﬂuorescence in livers of animals ex-
posed to PPD-immunization and kept on drug-free diet (see
Figure 4(a)). These cells may represent a set of not fully-
committedTh1cells,thusexhibitingIL-4+/IFN-γ+++ pheno-
type. Transient nature of the systemic Th1 response caused
by “spillover” of immune reactions in the lungs, occuring
after injection of PPD-coupled beads, may explain the fail-
ure of liver-associated T cells to complete the acquisition
of Th1-type phenotype. In PPD-immunized animals receiv-
ing DEHP-diet, however, liver associated T cells appear to
have fully acquired IL-4+++/IFN-γ− (Th2; green) pheno-
type (see Figure 4(b)). Taken together, our data support the
conclusion that Th1/Th2 balance in DEHP-treated animals
is shifted towards Th2 phenotypic response which amelio-
rated the eﬀects of the Th1-type response observed in PPD-
immunized animals on drug-free diet.
Transactivation assays showed that monoethylhexylph-
thalate (MEHP), the primary metabolite of DEHP [15], ac-
tivates PPARα which is abundant in the liver [8, 18], as well
as PPARγ [15]. However, MEHP is 5-fold more eﬀective as a
PPARα than PPARγ agonist [15], suggesting that the DEHP-
evoked eﬀect, observed in this study, is most likely mediated
throughthePPARα.Thisconclusionissupportedbyﬁndings
from our laboratories showing similar results by the PPARα
selective agonist, cloﬁbrate (Shnyra and Badr, unpublished
results).
TheprecisemechanisminvolvedinthisPPARα-mediated
immune deviation remains unclear. However, it has been
speculated that induction of GATA-3, a transcription fac-
tor and a master regulator of Th2 diﬀerentiation, may be
involved [6]. Induction of GATA-3 by PPARα agonists may
depend on STAT-6, another transcription factor associated
with Th2 response [6]. Interestingly, experimental evidence
suggeststhatimmune deviation regulatedbyPPARαmayoc-
cur, at least in part, via epigenetic mechanisms not involving
DNA binding [6].
4.2. Potentialimmune-relatedhealthhazards
duetoPPARαactivation
Despite the obvious beneﬁt of the PPAR-mediated protec-
tion of the liver against parenchymal damage caused by Th1
response, it is noteworthy that this eﬀect may occur at the
expense of other crucial functions of the immune system.
In the United States, nearly 40,000 individuals are in-
fected each year with the hepatitis C virus [19]. Although
a predominant Th1-like response is associated with a self-
limited infection [3], this response is not without potential
complications. Viral hepatitis is characterized by hepatocel-
lular necrosis, an eﬀect which is mediated by a Th1-like re-
sponse involving IFN-γ [3]. In addition, the activation of
liver-associated T lymphocytes has also been reported to play
a role in the pathogenesis of alcoholic hepatitis [20].
In contrast to the potentially beneﬁcial eﬀect of im-
mune deviation such as that occurring upon the activation
of PPARα [3, 6], and this study, upsetting the Th1/Th2 bal-
ance in favor of the Th2 response may also result in serious
consequences. For example, it has been shown that immune
deviation is associated with a signiﬁcant enhancement in the
replication, and invasion across mucosal membranes, of the
HIV virus [21]. Indeed, IL-4, a cytokine characteristic of Th-
2 immune responses, is critical for X4 virus replication [21].
Treatments which induced IL-4 led to highly productive vi-
ral replications in cultured macrophages and T cells, as well
as in vivo; an eﬀect which was abrogated by pretreatment
with IL-4 antisense [21]. Accordingly, it can be speculated
that exposure to PPARα activators may exacerbate the condi-
tion of individuals infected with the HIV virus by contribut-
ing to an immune environment favorable for enhanced viral
replication and opportunistic infections. Furthermore, im-
mune deviation is expected to interfere with the ability of the
immune system to mount a vigorous defense against other
viruses, leading to chronicity and potential hepatocarcino-
genicity in the case of hepatic infections.
Another potential health hazard that may result from ex-
posure to environmentally abundant PPAR activators, such
as the phthalate plasticizers [10–15, 22], stems from the fact
that Th2-associated cytokines play a role in the developmentMostafa Z. Badr et al. 5
Control
(a)
DEHP
(b)
Control
(c)
DEHP
(d)
Figure 3: Hepatic sublobular distribution of T cells in DEHP-treated rats. (a) Representative liver sections from rats on drug-free diet + naked
sepharose beads, group I; (b) DEHP diet + naked sepharose beads, group III; (c) drug-free diet + PPD-coupled sepharose beads, group II;
or (d) DEHP diet + PPD-coupled sepharose beads, group IV. Tissues from 5 animals per group were stained with hematoxylin and eosin
following standard techniques. Arrows point to representative T cells. Photos are 100x.
(a) (b)
Figure 4: Changes in liver-associated T cell cytokine pattern due to
DEHP. (a) Representative liver sections from rats fed either a drug-
free diet + PPD-coupled sepharose beads; or (b) DEHP diet + PPD-
coupled sepharose beads.
ofasthma;adiseasewhichhasemergedasaworldwidepublic
health problem associated with an increased risk of morbid-
ity and mortality [23]. Last but not least, immune deviation
may also hinder the ability of the immune system to respond
eﬃciently to vaccines, a response that seems strongly biased
toward Th1 activity [23].
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